Cost-Consequence Model Comparing Eltrombopag and Romiplostim for Pediatric Patients with Previously-Treated Chronic Immune Thrombocytopenia

被引：0
|
作者：
Tremblay, Gabriel
Bhor, Menaka
Roy, Anuja
Elliott, Brian
Dolph, Mike
Forsythe, Anna
Briggs, Andrew
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2146
引用
下载
收藏
页数：2
相关论文
共 27 条
  • [21] COST OF MANAGING BLEEDING-RELATED EPISODES (BRE) FOR ROMIPLOSTIM VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICO
    Arocho, R.
    Northridge, K.
    Rivera Hurtado, R.
    Chavez, J. G.
    VALUE IN HEALTH, 2011, 14 (07) : A568 - A569
  • [22] Evaluation of Treatment Patterns Among Patients with Newly Diagnosed, Persistent, and Chronic Immune Thrombocytopenia (ITP) Treated with Eltrombopag in Real World Setting in the US
    Stafkey-Mailey, Dana
    Roy, Anuja
    Lokhandwala, Tasneem
    Yuan, Jing
    Landsman-Blumberg, Pamela
    Siddiqui, Asif
    Ghaznawi, Farhat
    BLOOD, 2017, 130
  • [23] Safety and Efficacy of Thrombopoietin Receptor Agonists in Patients with Previously Treated Chronic Immune Thrombocytopenia: A Systematic Review and Meta-Analysis
    Yamada, Yuji
    Fujii, Takeo
    Cromwell, Caroline
    Shapira, Ilan
    BLOOD, 2016, 128 (22)
  • [24] SAFETY AND EFFICACY OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Yamada, Y.
    Fujii, T.
    Cromwell, C.
    Shapira, I.
    HAEMATOLOGICA, 2017, 102 : 588 - 588
  • [25] Evaluation of Bleeding-Related Episodes in Patients with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim in Two Phase 3 Placebo-Controlled Clinical Trials
    Weitz, Ilene Ceil
    Sanz, Miguel A.
    Henry, David H.
    Schipperus, Martin
    Godeau, Bertrand
    Gleeson, Michelle
    Danese, Mark
    Deuson, Robert
    BLOOD, 2009, 114 (22) : 367 - 367
  • [26] MODELING AND SIMULATION (M&S) SUPPORT ELTROMBOPAG (EPAG) DOSAGE ESCALATION BASED ON PLATELET COUNT FOR PEDIATRIC PATIENTS WITH PERSISTENT OR CHRONIC IMMUNE THROMBOCYTOPENIA (CITP)
    Grainger, J.
    Sirachainan, N.
    Wire, M. B.
    Aslanis, V.
    Sallas, W.
    Zhang, J.
    Bussel, J.
    HAEMATOLOGICA, 2016, 101 : 588 - 589
  • [27] RESULTS FROM PETIT2 (TRA115450): A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ELTROMBOPAG TREATMENT IN PEDIATRIC PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA
    Grainger, J. D.
    Locatelli, F.
    Chotsampancharoen, T.
    Donyush, E.
    Pongtanakul, B.
    Komvilaisak, P.
    Sosothikul, D.
    Drelichman, G.
    Sirachainan, N.
    Holzhauer, S.
    Lebedev, V.
    Lemons, R.
    Ramenghi, U.
    Bussel, J. B.
    Bakshi, K. K.
    Iyengar, M.
    Chan, G.
    Chagin, K.
    Theodore, D.
    Marcello, L.
    Bailey, C. K.
    HAEMATOLOGICA, 2014, 99 : 263 - 263
123